Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 3,1413,160 of 20,252 grants

Active RESEARCH CENTERS
Admin-Core-001
NATIONAL CANCER INSTITUTE Johns Hopkins University United States 2023 – 2027

Project Summary/Abstract: The mission of the Administration Core is to ensure that the individual Research Projects, and the Research Core combine with synergy beyond their individ...

Completed NON SBIR/STTR CONTRACTS
STABLE CLONE PRODUCTION FOR ANTI-EBV MONOCLONAL ANTIBODIES
NATIONAL CANCER INSTITUTE Leidos Biomedical Research, Inc United States 2023 – 2025

Epstein-Barr virus (EBV) is the major cause of post-transplant lymphoproliferative disease (PTLD) and EBV lymphoma in stem cell and organ transplant recipients. Persons who are EBV...

$337.6K
USD
Completed RESEARCH CENTERS
SUCCEED Administrative Core
NATIONAL CANCER INSTITUTE Virginia State University United States 2023 – 2025

ADMINISTRATIVE CORE: PROJECT SUMMARY The Administrative Core will provide scientific and programmatic leadership to ensure the unifying scientific mission of the Virginia State Uni...

Completed RESEARCH CENTERS
Pragmatic Implementation Science Approaches to Assess and Enhance Value of Cancer Prevention and Control in Rural Primary Care
NATIONAL CANCER INSTITUTE University of Colorado Denver United States 2023 – 2024

Project Summary/Abstract – Administrative Core The theme of our proposed Implementation Science Center is “Pragmatic implementation science approaches to assess and enhance the val...

Completed RESEARCH CENTERS
Pragmatic Implementation Science Approaches to Assess and Enhance Value of Cancer Prevention and Control in Rural Primary Care
NATIONAL CANCER INSTITUTE University of Colorado Denver United States 2023 – 2024

Project Summary/Abstract – Administrative Core The theme of our proposed Implementation Science Center is “Pragmatic implementation science approaches to assess and enhance the val...

Active RESEARCH CENTERS
Admin-Core-001
NATIONAL CANCER INSTITUTE University of Tx Md Anderson Can Ctr United States 2023 – 2027

ADMINISTRATIVE CORE – SUMMARY The proposed Acquired Resistance to Therapy and Iron (ARTI) Center is focused on the role of ferroptosis in acquired resistance to radiation therapy.R...

Active RESEARCH CENTERS
Administrative Core
NATIONAL CANCER INSTITUTE University of Massachusetts Boston United States 2023 – 2026

Summary: The Administrative Core of the University of Massachusetts, Boston (UMass Boston) and Dana- Farber/Harvard Cancer Center (DF/HCC) Partnership takes an integrated approach...

Active RESEARCH CENTERS
Admin-Core-001
NATIONAL CANCER INSTITUTE University of Tx Md Anderson Can Ctr United States 2023 – 2027

Administrative Core (Core A) SUMMARY The Administrative Core, led by Dr. Jeffrey Myers and Dr. Vlad Sandulache, and supported by the Center Administrator Dr. Toyin Babarinde, is an...

Active RESEARCH CENTERS
Metabolic adaptation enables cisplatin resistance and inhibits tumor immunity
NATIONAL CANCER INSTITUTE University of Tx Md Anderson Can Ctr United States 2023 – 2027

Head and neck squamous cell carcinoma (HNSCC) remains a leading cause of cancer death worldwide, with ~500,000 cases/year. Cisplatin is the gold standard systemic agent for HNSCC.C...

Active OTHER RESEARCH-RELATED
Determinants of resistance to engineered T-cell therapies targeting CD19 in lymphoma
NATIONAL CANCER INSTITUTE University of California-Irvine United States 2023 – 2028

Determinants of resistance to engineered T-cell therapies targeting CD19 in lymphoma The outcomes for patients with large B-cell lymphoma (LBCL) that are relapsed or refractory to...

$1.73M
USD
Active NON-SBIR/STTR RPGS
Modeling the equity impact of age restricted in-person location policies for youth tobacco use
NATIONAL CANCER INSTITUTE Ohio State University United States 2023 – 2028

PROJECT SUMMARY/ABSTRACT This proposal concerns age restricted in-person location policies (ARLPs), a novel tobacco control strategy that could have a critical impact on reducing y...

$5.99M
USD
Active NON-SBIR/STTR RPGS
Znf740 in the regulation of CD8+T cell exhaustion
NATIONAL CANCER INSTITUTE Ut Southwestern Medical Center United States 2023 – 2028

ABSTRACT: CAR-T cell therapy is an emerging option for cancer treatment, but its efficacy is limited, especially in solid tumors, because the effector CD8+T cells become dysfunctio...

$5.34M
USD
Active RESEARCH CENTERS
Project 2
NATIONAL CANCER INSTITUTE Lsu Health Sciences Center United States 2023 – 2028

HIV-associated Kaposi sarcoma (KS), also known as epidemic Kaposi sarcoma (EpKS), is a leading malignancy in sub-Saharan Africa (SSA). It is among the top 10 malignancies by incide...

Active RESEARCH CENTERS
Project 3
NATIONAL CANCER INSTITUTE Lsu Health Sciences Center United States 2023 – 2028

ABSTRACT Kaposi sarcoma (KS), an HIV/AIDS-associated malignancy, is one of the most prevalent cancers in people living with HIV-1 (PLWH) in sub-Saharan Africa (SSA). AIDS-associate...

Active RESEARCH CENTERS
Data Core
NATIONAL CANCER INSTITUTE Lsu Health Sciences Center United States 2023 – 2028

ABSTRACT The Data Management and Integration Core (DMIC) of the Kaposi Sarcoma (KS) in Era of Antiretroviral Therapy in Africa Program (KEAAP) is responsible for streamlining and c...

Active RESEARCH CENTERS
Developmental Core
NATIONAL CANCER INSTITUTE Lsu Health Sciences Center United States 2023 – 2028

ABSTRACT Human resource capacity building and training are urgently needed to establish a sustainable research enterprise that will improve prevention, diagnosis, connection to car...

Completed OTHER RESEARCH-RELATED
Elucidating the role of mRNA m6A methylation in tumorigenesis
NATIONAL CANCER INSTITUTE University of Chicago United States 2023 – 2025

PROJECT SUMMARY/ABSTRACT The current lack of effective, targeted cancer therapies reflects a gap in knowledge surrounding the mechanisms that promote tumorigenesis and emphasizes t...

$489.7K
USD
Completed OTHER RESEARCH-RELATED
Fibroblasts in the establishment of the liver pre-metastatic niche
NATIONAL CANCER INSTITUTE Oregon Health & Science University United States 2023 – 2025

PROJECT SUMMARY Postpartum breast cancer (PPBC), defined as breast cancer diagnosed within 10-years after a women's last childbirth, accounts for 50% of young women's bre...

$489.7K
USD
Completed OTHER RESEARCH-RELATED
Dissecting the tumor cell-immune TME axis to identify therapeutically actionable vulnerabilities that potentiate immunotherapy in GBM
NATIONAL CANCER INSTITUTE Johns Hopkins University United States 2023 – 2025

Glioblastoma multiforme (GBM) is a common and highly aggressive form of brain cancer in adults with a dismal prognosis and limited therapeutic options. A critical component of GBM...

$489.7K
USD
Active OTHER RESEARCH-RELATED
Deep Sequencing of Relapse and Refractory Hodgkin Lymphoma Genomes: A Study of Tumor Biology and Evolution
NATIONAL CANCER INSTITUTE Washington University United States 2023 – 2026

Hodgkin lymphoma (HL) accounts for ten percent of all lymphomas in the western world and remains a substantial clinical problem. Relapsed and refractory (R/R) HL presents a particu...

$1.94M
USD